High-pro­file R&D spe­cial­ist David Leb­wohl jumps to new job as CMO of a pi­o­neer­ing CRISPR play­er; Trou­bled AM­AG Phar­ma­ceu­ti­cals taps Scott My­ers as CEO

→ No­var­tis vet David Leb­wohl has found a new biotech to ply his trade.

A lit­tle more than a year ago, Leb­wohl joined the great mi­gra­tion out of No­var­tis, leav­ing his post as head of the CAR-T unit in late 2018 to take the CMO job at Sem­ma. Then Ver­tex snapped up Sem­ma and its cut­ting-edge work in re­gen­er­a­tive med­i­cine and now Leb­wohl is head­ed to CRISPR/Cas9 pi­o­neer In­tel­lia as chief med­ical of­fi­cer.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER